WBB Securities Initiates Coverage on Seattle Genetics (SGEN) with a 'Sell'
Tweet Send to a FriendGet Alerts SGEN Hot Sheet
Price: $31.49 --0%
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Trade SGEN Now!
WBB Securities initiates coverage on Seattle Genetics (Nasdaq: SGEN) with a Sell rating. PT $10.75.
To see all the upgrades/downgrades on shares of SGEN, visit our Analyst Ratings page.
Seattle Genetics, Inc. (Seattle Genetics) is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
To see all the upgrades/downgrades on shares of SGEN, visit our Analyst Ratings page.
Seattle Genetics, Inc. (Seattle Genetics) is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
- Wells Fargo Starts StealthGas (GASS) at Outperform
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
